GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Compugen Ltd (XTAE:CGEN) » Definitions » Cash Flow for Dividends

Compugen (XTAE:CGEN) Cash Flow for Dividends : ₪0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Compugen Cash Flow for Dividends?

Compugen's cash flow for dividends for the three months ended in Sep. 2024 was ₪0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was ₪0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Compugen Cash Flow for Dividends Historical Data

The historical data trend for Compugen's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compugen Cash Flow for Dividends Chart

Compugen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Compugen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Compugen Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compugen Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Compugen's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Compugen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Compugen Ltd (XTAE:CGEN) » Definitions » Cash Flow for Dividends
Comparable Companies
XTAE:BONS XTAE:GFC-M XTAE:BLRX XTAE:DNA XTAE:MTLF XTAE:CBI XTAE:KDST XTAE:CANF XTAE:XTLB XTAE:EVGN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
CGEN:USA
Address
26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849
Website
https://www.cgen.com
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.